Collectively, these results demonstrate that our co-assembly strategy effectively degrades IL-17A both in vitro and in vivo and displays potent anti-inflammatory activity, successfully ameliorating psoriasis symptoms in the IMQ-induced mouse model. This evidence concerns the gene IL17A and psoriasis.